legal-news
2:26-cv-03509 ULTRAGENYX PHARMACEUTICAL INC. et al v. SOMERSET THERAPEUTICS LLC et al
scheduleUpdated 21 hours ago
26-cv-03509
|
|
Filed
Advertisement
description
Case Summary
A corporate disclosure statement (aty) has been filed by Ultragenyx Pharmaceutical Inc. and Somerset Therapeutics LLC in docket 26-cv-03509. The current summary provides limited information about the nature of the disclosure and its legal implications.
Stage
Active litigation
Timeline
1 event
Coverage
1 article
Sources
1
Key Issues
- • Corporate disclosure statement
- • Ultragenyx Pharmaceutical Inc
- • Somerset Therapeutics LLC
update What Changed This Week
1 event
1 article
newspaper
pacer
22 hours, 10 minutes ago
2:26-cv-03509 ULTRAGENYX PHARMACEUTICAL INC. et al v. SOMERSET THERAPEUTICS LLC
info
Other
22 hours, 35 minutes ago
2:26-cv-03509 ULTRAGENYX PHARMACEUTICAL INC. et al v. SOMERSET THERAPEUTICS LLC
Advertisement
Case Timeline
1 event
info
Other
April 16, 2026
2:26-cv-03509 ULTRAGENYX PHARMACEUTICAL INC. et al v. SOMERSET THERAPEUTICS LLC et al
In a corporate legal matter, Ultragenyx Pharmaceutical Inc. and Somerset Therapeutics LLC are involved in a case that includes a Corporate Disclosure Statement (Form 10). The details of the event are not specified, but the case highlights the importance of transparency and compliance in corporate disclosures.
Advertisement
show_chart
Coverage Timeline
newspaper
1 article